Matches in SemOpenAlex for { <https://semopenalex.org/work/W3029727868> ?p ?o ?g. }
Showing items 1 to 86 of
86
with 100 items per page.
- W3029727868 endingPage "850" @default.
- W3029727868 startingPage "847" @default.
- W3029727868 abstract "Objective To investigate the changes of Tc1/Tc2 profiles and the cytotoxic function of CD8+ cells in ovarian cancer patients undergoing paclitaxel and carboplatin chemotherapy, so as to identify whether there is a window period of anti-tumor immune suppression reverse after chemotherapy. Methods Blood samples from each ovarian cancer patient were obtained before (S0) and at day 5-7 (S1), day 12-14 (S2) and day 25-28 (S3) after chemotherapy in 13 patients. Thirteen age-matched healthy female volunteers were enrolled as a control group. Flow cytometry technique was employed to analyze the proportion of Tc1/Tc2. The numbers of specific IFN-γ, secreting CD8+ cells were also calculated after peripheral lymphocytes had been stimulated with self tumor lysates. Results The proportion of Tel in CD8+ cells increased re-markably on S2 while the proportion of Tc2 in CD8+ cells remained no significant changes after chemothera-py. The ratio of Tc1 to Tc2 cells reached the highest on S2. IFN-γ/secreting CD8+ T cells also increased re-markably on S2, especially when CD8+ T cells were stimulated with autologous tumor antigen. Conclusion Paclitaxel and carboplatin induce the changes of Tc1/Tc2 profile and augment anti-tumor immune response by immune reconstitution. It probably turns out that the window period during immune reconstitution offers a best opportunity for cancer immunotherapy.Key words: Ovarian cancer; Chemotherapy; Tc1/Tc2; Immune response" @default.
- W3029727868 created "2020-06-05" @default.
- W3029727868 creator A5004921007 @default.
- W3029727868 creator A5009029509 @default.
- W3029727868 creator A5068956785 @default.
- W3029727868 date "2009-09-30" @default.
- W3029727868 modified "2023-09-28" @default.
- W3029727868 title "The Tc1/Tc2 profiles and anti-tumor immune response in advanced ovarian cancer patients undergo-ing paclitaxei and carboplatin chemotherapy" @default.
- W3029727868 doi "https://doi.org/10.3760/cma.j.issn.0254-5101.2009.09.019" @default.
- W3029727868 hasPublicationYear "2009" @default.
- W3029727868 type Work @default.
- W3029727868 sameAs 3029727868 @default.
- W3029727868 citedByCount "0" @default.
- W3029727868 crossrefType "journal-article" @default.
- W3029727868 hasAuthorship W3029727868A5004921007 @default.
- W3029727868 hasAuthorship W3029727868A5009029509 @default.
- W3029727868 hasAuthorship W3029727868A5068956785 @default.
- W3029727868 hasConcept C121608353 @default.
- W3029727868 hasConcept C126322002 @default.
- W3029727868 hasConcept C143998085 @default.
- W3029727868 hasConcept C154317977 @default.
- W3029727868 hasConcept C167672396 @default.
- W3029727868 hasConcept C202751555 @default.
- W3029727868 hasConcept C203014093 @default.
- W3029727868 hasConcept C2776694085 @default.
- W3029727868 hasConcept C2777292972 @default.
- W3029727868 hasConcept C2777701055 @default.
- W3029727868 hasConcept C2778239845 @default.
- W3029727868 hasConcept C2780427987 @default.
- W3029727868 hasConcept C2781451048 @default.
- W3029727868 hasConcept C502942594 @default.
- W3029727868 hasConcept C553184892 @default.
- W3029727868 hasConcept C55493867 @default.
- W3029727868 hasConcept C71924100 @default.
- W3029727868 hasConcept C86803240 @default.
- W3029727868 hasConcept C8891405 @default.
- W3029727868 hasConceptScore W3029727868C121608353 @default.
- W3029727868 hasConceptScore W3029727868C126322002 @default.
- W3029727868 hasConceptScore W3029727868C143998085 @default.
- W3029727868 hasConceptScore W3029727868C154317977 @default.
- W3029727868 hasConceptScore W3029727868C167672396 @default.
- W3029727868 hasConceptScore W3029727868C202751555 @default.
- W3029727868 hasConceptScore W3029727868C203014093 @default.
- W3029727868 hasConceptScore W3029727868C2776694085 @default.
- W3029727868 hasConceptScore W3029727868C2777292972 @default.
- W3029727868 hasConceptScore W3029727868C2777701055 @default.
- W3029727868 hasConceptScore W3029727868C2778239845 @default.
- W3029727868 hasConceptScore W3029727868C2780427987 @default.
- W3029727868 hasConceptScore W3029727868C2781451048 @default.
- W3029727868 hasConceptScore W3029727868C502942594 @default.
- W3029727868 hasConceptScore W3029727868C553184892 @default.
- W3029727868 hasConceptScore W3029727868C55493867 @default.
- W3029727868 hasConceptScore W3029727868C71924100 @default.
- W3029727868 hasConceptScore W3029727868C86803240 @default.
- W3029727868 hasConceptScore W3029727868C8891405 @default.
- W3029727868 hasIssue "09" @default.
- W3029727868 hasLocation W30297278681 @default.
- W3029727868 hasOpenAccess W3029727868 @default.
- W3029727868 hasPrimaryLocation W30297278681 @default.
- W3029727868 hasRelatedWork W2349547145 @default.
- W3029727868 hasRelatedWork W2353674681 @default.
- W3029727868 hasRelatedWork W2353937359 @default.
- W3029727868 hasRelatedWork W2358264286 @default.
- W3029727868 hasRelatedWork W2360256348 @default.
- W3029727868 hasRelatedWork W2365008155 @default.
- W3029727868 hasRelatedWork W2365328964 @default.
- W3029727868 hasRelatedWork W2365914703 @default.
- W3029727868 hasRelatedWork W2368382755 @default.
- W3029727868 hasRelatedWork W2368417197 @default.
- W3029727868 hasRelatedWork W2377302176 @default.
- W3029727868 hasRelatedWork W2382410381 @default.
- W3029727868 hasRelatedWork W2385617155 @default.
- W3029727868 hasRelatedWork W2386916138 @default.
- W3029727868 hasRelatedWork W2896640751 @default.
- W3029727868 hasRelatedWork W2964168587 @default.
- W3029727868 hasRelatedWork W3030188325 @default.
- W3029727868 hasRelatedWork W3031471824 @default.
- W3029727868 hasRelatedWork W3161676085 @default.
- W3029727868 hasRelatedWork W870358426 @default.
- W3029727868 hasVolume "29" @default.
- W3029727868 isParatext "false" @default.
- W3029727868 isRetracted "false" @default.
- W3029727868 magId "3029727868" @default.
- W3029727868 workType "article" @default.